TABLE 3.
Outcomes | Coronavirus Disease 2019(n = 2,635) | Nonsevere Acute Respiratory Syndrome Coronavirus 2 Viral Pneumonia (n = 2,940) | Bacterial Pneumonia (n = 14,250) | Trauma (n = 15,681) | p |
---|---|---|---|---|---|
LOS ICU of survived patients, d | 18 (10–33) | 4 (2–8)a | 3 (2–7)a | 1 (1–3)a | < 0.001 |
LOS ICU deceased patients, d | 10 (5–18) | 5 (2–9)a | 4 (1–8)a | 2 (1–6)a | < 0.001 |
LOS hospital of survived patients, d | 31 (19–46) | 11 (7–18)a | 12 (7–20)a | 9 (5–16)a | < 0.001 |
LOS hospital of deceased patients, d | 12 (6–19) | 7 (3–13)a | 7 (3–13)a | 5 (2–10)a | < 0.001 |
Number of readmissions | 11 (0.4) | 48 (1.6)a | 1,348 (8.6)a | 238 (1.5)a | < 0.001 |
28-d mortality, n (%) | 660 (25.0) | 507 (17.2)a | 2,858 (20.1)a | 1,394 (8.9)a | < 0.001 |
Inhospital mortality, n (%) | 769 (29.2) | 545 (18.5)a | 3,019 (21.2)a | 1,456 (9.3)a | < 0.001 |
Odds ratios, kg/m2 | |||||
BMI < 18.5 | 1.92 (0.51–7.13) | 1.50 (0.95–2.37) | 1.88 (1.57–2.25) | 1.23 (0.86–1.78) | |
BMI 18.5–25 | 1.0 (reference) | 1.0 (reference) | 1.0 (reference) | 1.0 (reference) | |
BMI 25–30 | 0.95 (0.75–1.21) | 0.78 (0.61–0.99) | 0.78 (0.70–0.86) | 0.9 (0.78–1.03) | |
BMI 30–35 | 0.87 (0.65–1.16) | 0.76 (0.55–1.04) | 0.81 (0.70–0.93) | 0.99 (0.79–1.23) | |
BMI ≥ 35 | 1.15 (0.79–1.67) | 0.64 (0.43–0.95) | 0.73 (0.61–0.87) | 0.81 (0.57–1.15) |
BMI = body mass index, LOS = length of stay.
ap < 0.001 compared with coronavirus disease 2019 using pairwise χ2 or Wilcoxon tests.
Covariates used for the multivariable logistic regression analyses included sex, age, medical history (chronic diagnoses), Acute Physiology and Chronic Health Evaluation III Acute Physiology Score, vasoactive medication, mechanical ventilation, and Pao2/Fio2 ratio on ICU admission.
Data presented as median (interquartile range) or n (%). p values calculated using χ2 tests or Kruskal-Wallis tests across all four cohorts.